Finally GSTP1 expression could potentially represent a good histological marker in substitution of or in addition to AMACR, p63, or cytokeratin [20–22], already used in clinical practice, so as to improve PCa detection when diagnosis is ambiguous due to the presence of cancer mimics such as PIN. This evidence concerns the gene GSTP1 and prostate intraepithelial neoplasia.